Changes in the menstrual bleeding of users of a subdermal contraceptive implant of nomegestrol acetate (Uniplant) do not influence sexual frequency, sexual desire, or sexual enjoymentt

Factors affecting sexual function in premenopausal age women with type 2 diabetes: a comprehensive study

“…The effect of menopause on sexual function is a relatively wellstudied subject in female sexual response compared with the premenopausal period (20)(21)(22)(23)(24) Regarding the relationship between menstruation and sexual function, some investigators found that the phases of the menstrual cycle had an effect on sexual function in women with type 1 diabetes (25,26). Some investigators studied the possible relationship between irregular menstruation and sexual dysfunction in premenopausal women without systemic disease (27,28). Most of them also examined the hormonal profile of the women and reported that changes in hormonal profiles were responsible for menstrual disturbances leading to poor sexual function.…”

Contraception and sexual health

“…Paul et al [ 15 ] reported that only 2.3% of users (women in New Zealand) discontinued because of reduced libido, whereas Li et al [ 16 ] found in a prospective study of Chinese women in Hong Kong that the use of DMPA had no impact on sexual activity and, in that regard, was the same as OCs. No adverse impact on sexuality was found for women using a progestin-only implant [ 17 ] or progestin-only pills [ 18 ]. These fi ndings are surprising given the reduction in circulating androgens observed in women using a progestin-only method.…”

Implantable contraceptives for women

“…Symptoms such as nausea, breast tenderness, pelvic pain, loss of libido and fatigue have each been reported by small proportions of implant users (Brache et al, 2002). In comparative trials with non-hormonal methods, most of these symptoms have not differed between the two groups, and their incidence probably re¯ects their occurrence in the general population (Sivin, 1983;Barnhart et al, 1997;International Collaborative Post-marketing Surveillance of Norplant, 2001a,b;Meirik et al, 2001); however, a small effect of the implants cannot always be excluded (International Collaborative Post-marketing Surveillance of Norplant, 2001b). Each of these diverse symptoms typically led to discontinuation in less than 0.5% of users (Brache et al, 2002).…”